Global Bacteriophage Therapy Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis

Chapter 1 Bacteriophage Therapy Market Overview

1.1 Bacteriophage Therapy Definition

1.2 Global Bacteriophage Therapy Market Size Status and Outlook (2019-2032)

1.3 Global Bacteriophage Therapy Market Size Comparison by Region (2019-2032)

1.4 Global Bacteriophage Therapy Market Size Comparison by Type (2019-2032)

1.5 Global Bacteriophage Therapy Market Size Comparison by Application (2019-2032)

1.6 Global Bacteriophage Therapy Market Size Comparison by Sales Channel (2019-2032)

1.7 Bacteriophage Therapy Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Bacteriophage Therapy Market Snapshot

2.2 Global Bacteriophage Therapy Market Volume & Revenue (2019-2025)

2.3 Global Bacteriophage Therapy Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)

2.4 Global Bacteriophage Therapy Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)

2.5 Global Bacteriophage Therapy Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)

2.6 Global Bacteriophage Therapy Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)

Chapter 3 Bacteriophage Therapy Market Segment Analysis by Player

3.1 Global Bacteriophage Therapy Sales and Market Share by Player (2023-2025)

3.2 Global Bacteriophage Therapy Revenue and Market Share by Player (2023-2025)

3.3 Global Bacteriophage Therapy Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Bacteriophage Therapy Market Segment Analysis by Type

4.1 Global Bacteriophage Therapy Market by Type

4.1.1 DsDNA Bacteriophage

4.1.2 SsDNA Bacteriophage

4.1.3 SsRNA Bacteriophage

4.1.4 Others

4.2 Global Bacteriophage Therapy Sales and Market Share by Type (2019-2025)

4.3 Global Bacteriophage Therapy Revenue and Market Share by Type (2019-2025)

4.4 Global Bacteriophage Therapy Average Price by Type (2019-2025)

4.5 Leading Players of Bacteriophage Therapy by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Bacteriophage Therapy Market Segment Analysis by Application

5.1 Global Bacteriophage Therapy Market by Application

5.1.1 Animal Health

5.1.2 Human Health

5.1.3 Agriculture

5.1.4 Food Industry

5.1.5 Others

5.2 Global Bacteriophage Therapy Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Bacteriophage Therapy by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Bacteriophage Therapy Market Segment Analysis by Sales Channel

6.1 Global Bacteriophage Therapy Market by Sales Channel

6.1.1 Global Bacteriophage Therapy Market, by Direct Channel Market Analysis (2019-2032) (USD Million)

6.1.2 Global Bacteriophage Therapy Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)

6.2 Global Bacteriophage Therapy Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Bacteriophage Therapy by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Bacteriophage Therapy Market Segment Analysis by Region

7.1 Global Bacteriophage Therapy Market Size and CAGR by Region (2019-2032)

7.2 Global Bacteriophage Therapy Sales and Market Share by Region (2019-2025)

7.3 Global Bacteriophage Therapy Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Bacteriophage Therapy Market Share by Type

7.4.3 North America Bacteriophage Therapy Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Bacteriophage Therapy Market Share by Type

7.5.3 Europe Bacteriophage Therapy Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Bacteriophage Therapy Market Share by Type

7.6.3 Asia-Pacific Bacteriophage Therapy Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Bacteriophage Therapy Market Share by Type

7.7.3 South America Bacteriophage Therapy Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Bacteriophage Therapy Market Share by Type

7.8.3 Middle East & Africa Bacteriophage Therapy Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.9.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Bacteriophage Therapy Players

8.1 Phagelux

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 Intralytix

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 Micreos

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 Eliava BioPreparations

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 Locus Biosciences

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 Pharmex Group

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 Pherecydes Pharma

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

8.8 APS Biocontrol

8.8.1 Company Snapshot

8.8.2 Product/Service Offered

8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.8.4 Recent Developments

8.9 Qingdao Phagepharm Bio-tech

8.9.1 Company Snapshot

8.9.2 Product/Service Offered

8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.9.4 Recent Developments

8.10 Zeptometrix

8.10.1 Company Snapshot

8.10.2 Product/Service Offered

8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.10.4 Recent Developments

8.11 Phage International

8.11.1 Company Snapshot

8.11.2 Product/Service Offered

8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.11.4 Recent Developments

8.12 CJ Cheiljedang

8.12.1 Company Snapshot

8.12.2 Product/Service Offered

8.12.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.12.4 Recent Developments

8.13 Aristogene

8.13.1 Company Snapshot

8.13.2 Product/Service Offered

8.13.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.13.4 Recent Developments

8.14 Armata Pharmaceuticals

8.14.1 Company Snapshot

8.14.2 Product/Service Offered

8.14.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.14.4 Recent Developments

8.15 Innophage

8.15.1 Company Snapshot

8.15.2 Product/Service Offered

8.15.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.15.4 Recent Developments

8.16 Adaptive Phage Therapeutics

8.16.1 Company Snapshot

8.16.2 Product/Service Offered

8.16.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.16.4 Recent Developments

8.17 TechnoPhage

8.17.1 Company Snapshot

8.17.2 Product/Service Offered

8.17.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.17.4 Recent Developments

8.18 Cytophage

8.18.1 Company Snapshot

8.18.2 Product/Service Offered

8.18.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.18.4 Recent Developments

8.19 Others

8.19.1 Company Snapshot

8.19.2 Product/Service Offered

8.19.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.19.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Bacteriophage Therapy

9.1 Industrial Chain of Bacteriophage Therapy

9.2 Upstream of Bacteriophage Therapy

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Bacteriophage Therapy

9.3.1 Leading Distributors/Dealers of Bacteriophage Therapy

9.3.2 Leading Consumers of Bacteriophage Therapy

Chapter 10. Global Bacteriophage Therapy Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Bacteriophage Therapy Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Bacteriophage Therapy Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Bacteriophage Therapy (2026-2032)

11.1 Global Bacteriophage Therapy Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Bacteriophage Therapy Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Bacteriophage Therapy Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Bacteriophage Therapy Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Bacteriophage Therapy Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Bacteriophage Therapy Import-Export (2019-2025)

12.2 Europe Bacteriophage Therapy Import-Export (2019-2025)

12.3 Asia Pacific Bacteriophage Therapy Import-Export (2019-2025)

12.4 South America Bacteriophage Therapy Import-Export (2019-2025)

12.5 Middle East & Africa Bacteriophage Therapy Import-Export (2019-2025)

Chapter 13. Demand-Supply Gap Analysis

13.1 North America Bacteriophage Therapy Demand-Supply (2019-2025)

13.2 Europe Bacteriophage Therapy Demand-Supply (2019-2025)

13.3 Asia Pacific Bacteriophage Therapy Demand-Supply (2019-2025)

13.4 South America Bacteriophage Therapy Demand-Supply (2019-2025)

13.5 Middle East & Africa Bacteriophage Therapy Demand-Supply (2019-2025)

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources